334 related articles for article (PubMed ID: 8467862)
1. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
[TBL] [Abstract][Full Text] [Related]
3. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
Kahl U; Langel U; Bartfai T; Grundemar L
Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.
Dumont Y; Satoh H; Cadieux A; Taoudi-Benchekroun M; Pheng LH; St-Pierre S; Fournier A; Quirion R
Eur J Pharmacol; 1993 Jul; 238(1):37-45. PubMed ID: 8405081
[TBL] [Abstract][Full Text] [Related]
5. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.
Jørgensen JC; Fuhlendorff J; Schwartz TW
Eur J Pharmacol; 1990 Sep; 186(1):105-14. PubMed ID: 2178092
[TBL] [Abstract][Full Text] [Related]
6. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Grundemar L
Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
[TBL] [Abstract][Full Text] [Related]
8. Evidence for two neuropeptide Y receptors mediating vasoconstriction.
Modin A; Pernow J; Lundberg JM
Eur J Pharmacol; 1991 Oct; 203(2):165-71. PubMed ID: 1666044
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y inhibits 3[H]noradrenaline release in the rat vas deferens independently of cAMP levels.
Bitran M; Torres G; Tapia W; Huidobro-Toro JP
Neurochem Int; 1996 Mar; 28(3):309-17. PubMed ID: 8813249
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vascular neuropeptide Y receptors.
Grundemar L; Jonas SE; Mörner N; Högestätt ED; Wahlestedt C; Håkanson R
Br J Pharmacol; 1992 Jan; 105(1):45-50. PubMed ID: 1317737
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
12. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
14. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
Palea S; Corsi M; Rimland JM; Trist DG
Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
[TBL] [Abstract][Full Text] [Related]
15. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
Xia J; Neild TO; Kotecha N
Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
[TBL] [Abstract][Full Text] [Related]
17. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
[TBL] [Abstract][Full Text] [Related]
18. Differential actions of lamprey peptide methionine-tyrosine at Y1 and Y2 neuropeptide Y receptors.
Porter JE; Balasubramaniam A; Abel PW; Conlon JM
Regul Pept; 1994 Dec; 54(2-3):489-93. PubMed ID: 7716281
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vasoconstriction and Ca2+ currents mediated by neuropeptide Y Y2 receptors.
Lewis CJ; Evans RJ; Neild TO
J Smooth Muscle Res; 1999; 35(5-6):147-56. PubMed ID: 10733151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
